Skip to search.
 TSX Down 0.44% TSX Ventures Up 0.18%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
1.06 Up 0.06(6.00%) 10:31AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:1.00
Open:1.03
Bid:1.06 x 100
Ask:1.07 x 100
1y Target Est:1.30
Beta:1.7
Next Earnings Date:N/A
Day's Range:1.02 - 1.09
52wk Range:0.91 - 4.10
Volume:43,347
Avg Vol (3m):133,755
Market Cap:10.29M
P/E (ttm):N/A
EPS (ttm):-1.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHUp 6.00%10.29M
LLYDown 0.10%76.73B
ONXX 0.00%N/A
PFEUp 0.07%214.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:4.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback